Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
Making a 75-milligram vial available alongside the two current options of 200 milligrams and 500 milligrams could save ...
Medpage Today on MSN3d
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of MillionsAn estimated $133 million to $336 million worth of lecanemab may be discarded every year. Adding a 75-mg vial could save ...
A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...
On average, patients with Alzheimer disease and related dementias spend $1199.70 per year on out-of-pocket prescription drug costs.
Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...
Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown ...
Preclinical research in fruit flies and cell cultures suggests that a dual-targeting drug could help prevent the accumulation ...
On Monday, Eli Lilly And Co (NYSE:LLY) announced plans to boost its presence in the U.K., following a collaboration with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback